Inherited erythromelalgia drug pipeline
Rare inherited pain disorder caused by gain-of-function SCN9A (NaV1.7) mutations.
Compounds in development
No compounds populated for this indication yet.
Rare inherited pain disorder caused by gain-of-function SCN9A (NaV1.7) mutations.
No compounds populated for this indication yet.